Evidence map›Paper›PMID 33996815›Full record

ArticleFrontiers in cell and developmental biology2021

Mengqi Gao, Yi Lin, Xing Liu, Zheng Zhao, Zhiyuan Zhu, Hongbo Zhang, Yunchao Ban, Yanan Bie, Xiaozheng He, Xiang Sun and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Interactions between glioblastoma and myeloid cells.Frontiers in cell and developmental biology · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. AssociatingAJNR. American journal of neuroradiology · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Mengqi GaoGuangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Department of Functional Neurosurgery, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Yi LinDepartment of Neurosurgery, The First Hospital of China Medical University, Shenyang, China.
Xing LiuChinese Glioma Genome Atlas Network, Beijing, China.
Zheng ZhaoChinese Glioma Genome Atlas Network, Beijing, China.
Zhiyuan ZhuGuangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Department of Functional Neurosurgery, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Hongbo ZhangGuangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Department of Functional Neurosurgery, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Yunchao BanDepartment of Neurosurgery, The First Hospital of China Medical University, Shenyang, China.
Yanan BieSchool of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
Xiaozheng HeGuangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Department of Functional Neurosurgery, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Xiang SunGuangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Department of Functional Neurosurgery, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Shizhong ZhangGuangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Department of Functional Neurosurgery, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Southern Medical University · CNChina Medical University · CNZhujiang Hospital · CNBeijing Tian Tan Hospital · CNGuangdong Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutation of the telomerase reverse transcriptase (TERT) promoter has been demonstrated as an unfavorable prognostic marker in patients with isocitrate dehydrogenase wild-type (IDHwt) glioma. This study aimed to investigate the immune role of

Indexed as

chemokinesgliomaIDH mutationneutrophilRNA-seqTERT mutation

Identifiers

PMID33996815
PMCPMC8119999
OpenAlexW3158283057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.